SFS
REGN icon

Stiles Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Stiles Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Sell
3,564
-86
-2% -$58.5K 0.56% 53
2026
Q1 		$2.82M Sell
3,650
-361
-9% -$276K 0.86% 39
2025
Q4 		$3.1M Sell
4,011
-342
-8% -$232K 0.95% 28
2025
Q3 		$2.45M Sell
4,353
-5
-0.1% -$2.83K 0.77% 43
2025
Q2 		$2.29M Buy
4,358
+262
+6% +$146K 0.79% 46
2025
Q1 		$2.6M Buy
4,096
+200
+5% +$138K 1% 29
2024
Q4 		$2.77M Buy
3,896
+464
+14% +$389K 1% 29
2024
Q3 		$3.61M Buy
3,432
+89
+3% +$99K 1.27% 17
2024
Q2 		$3.51M Buy
3,343
+64
+2% +$62K 1.35% 16
2024
Q1 		$3.16M Buy
3,279
+246
+8% +$234K 1.26% 18
2023
Q4 		$2.66M Buy
3,033
+334
+12% +$275K 1.21% 25
2023
Q3 		$2.22M Buy
2,699
+753
+39% +$592K 1.15% 21
2023
Q2 		$1.4M Buy
1,946
+571
+42% +$440K 0.69% 48
2023
Q1 		$1.13M Buy
1,375
+385
+39% +$290K 0.61% 54
2022
Q4 		$714K Buy
+990
New +$730K 0.41% 71

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Stiles Financial Services's REGN Position: Q2 2026 in Review

Stiles Financial Services reduced its Regeneron Pharmaceuticals (REGN) stake by 2.4% in Q2 2026, selling an estimated $58.5K and leaving 3,564 shares worth $2.22M. The position accounts for 0.56% of the portfolio, ranked #53.

Stiles Financial Services first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.61M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Stiles Financial Services held 3,564 shares of Regeneron Pharmaceuticals worth $2.22M as of Q2 2026.
  • Stiles Financial Services sold 86 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $58.5K.
  • Regeneron Pharmaceuticals made up 0.56% of Stiles Financial Services's portfolio in Q2 2026, its #53 holding.
  • Stiles Financial Services first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Stiles Financial Services's Regeneron Pharmaceuticals position peaked at $3.61M in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Stiles Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.